EXCEED THE SPACE PROVIDED, This proposal aims at improving our understanding of the mechanisms by which facilitator membrane transport proteins function. Our main focus is on the facilitative glucose transporter Glut1, which has been the subject of many biochemical and mutagenesis studies, and is a prototype for the 'major facilitator superfamily'. We have recently published a 3-D model of Glut1 structure. The quality factors and Ramachandran scores for our structure are at least as good as those for membrane proteins with known coordinates (AQP1 and Kcsa), and our structure accounts for existing evidence for Glut1. We propose to test our structure by pursuing the following specific aims.
Aim #1. Further refinement and development of the Glut1 modeled structure. A) We will seek to complement the conclusions drawn from our structure with information on the dynamic characteristics of it. For this, we propose to run -1 ns molecular dynamics simulations of Glut1 in a lipid bilayer and surrounded by solvent. B) We will then reanalyze the resulting structure, seeking to delineate the transport pathways, including potential docking, binding, and selectivity sites, and to understand their dynamic behavior.
Aim #2. Cysteine mutagenesis studies on the predicted Glut1 transport pathways. Of the helices that line transport pathways, some have not been investigated by mutagenesis. Therefore, for residues predicted to line the channels, we propose to perform cysteine mutagenesis followed by tests of SH reagent accessibility and hence solvent accessibility. In addition, several pathogenic missense mutated residues appear to line either one of the channels. We will perform cysteine mutations at such locations to assess solvent accessibility. Functional assays will employ the Xenopus laevis oocyte expression system, and will include determinations of transport of substrates, kinetic analysis, and also determinations of water permeability.
Aim #3. Comprehensive kinetic analysis and molecular dynamics simulation of selected mutants. It is accepted that conformational changes are an integral part of Glut1 operation. Hence, we will perform molecular dynamics simulations to assess the mobility of Glut1 and possible changes in its transport pathways. Questions include whether the structural pathway(s) for substrates (glucose, dehydroascorbic acid (DHA)) and water passage can account for their migration, and where in the structure are binding and regulatory sites. PERFORMANCE SITE ========================================Section End===========================================

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY008918-12
Application #
6829703
Study Section
Visual Sciences A Study Section (VISA)
Program Officer
Fisher, Richard S
Project Start
1992-05-01
Project End
2005-11-30
Budget Start
2004-12-01
Budget End
2005-11-30
Support Year
12
Fiscal Year
2005
Total Cost
$367,875
Indirect Cost
Name
Columbia University (N.Y.)
Department
Ophthalmology
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Rodriguez, Patricio; Rivas, Coralia I; Godoy, Alejandro et al. (2005) Redefining the facilitated transport of mannose in human cells: absence of a glucose-insensitive, high-affinity facilitated mannose transport system. Biochemistry 44:313-20
Manolescu, Andrei; Salas-Burgos, Alexis M; Fischbarg, Jorge et al. (2005) Identification of a hydrophobic residue as a key determinant of fructose transport by the facilitative hexose transporter SLC2A7 (GLUT7). J Biol Chem 280:42978-83
Salas-Burgos, Alexis; Iserovich, Pavel; Zuniga, Felipe et al. (2004) Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules. Biophys J 87:2990-9
Wang, Dong; Pascual, Juan M; Iserovich, Pavel et al. (2003) Functional studies of threonine 310 mutations in Glut1: T310I is pathogenic, causing Glut1 deficiency. J Biol Chem 278:49015-21
Manning, Suzanne K; Woodrow, Charles; Zuniga, Felipe A et al. (2002) Mutational analysis of the hexose transporter of Plasmodium falciparum and development of a three-dimensional model. J Biol Chem 277:30942-9
Reyes, Alejandro M; Bustamante, Fernando; Rivas, Coralia I et al. (2002) Nicotinamide is not a substrate of the facilitative hexose transporter GLUT1. Biochemistry 41:8075-81
Iserovich, Pavel; Wang, Dong; Ma, Li et al. (2002) Changes in glucose transport and water permeability resulting from the T310I pathogenic mutation in Glut1 are consistent with two transport channels per monomer. J Biol Chem 277:30991-7
Brockmann, K; Wang, D; Korenke, C G et al. (2001) Autosomal dominant glut-1 deficiency syndrome and familial epilepsy. Ann Neurol 50:476-85
Ho, Y Y; Yang, H; Klepper, J et al. (2001) Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro. Pediatr Res 50:254-60
Izard, T (2001) Structural basis for chloramphenicol tolerance in Streptomyces venezuelae by chloramphenicol phosphotransferase activity. Protein Sci 10:1508-13

Showing the most recent 10 out of 28 publications